Permanent insulin‐dependent diabetes mellitus in a patient with acute lymphoblastic leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics international 2020-03, Vol.62 (3), p.403-405
Hauptverfasser:	Akane, Yusuke, Yamamoto, Masaki, Igarashi, Keita, Takebayashi, Akira, Hori, Tsukasa
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute lymphoblastic leukemia Adolescent Adrenal Cortex Hormones - adverse effects Adrenal Cortex Hormones - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Asparaginase - adverse effects Asparaginase - therapeutic use Blood Glucose - analysis corticosteroid Cyclophosphamide - adverse effects Cyclophosphamide - therapeutic use Cytarabine - adverse effects Cytarabine - therapeutic use Dexamethasone - adverse effects Dexamethasone - therapeutic use Diabetes mellitus Diabetes Mellitus, Type 1 - chemically induced Diabetes Mellitus, Type 1 - diagnosis Diabetes Mellitus, Type 1 - drug therapy Doxorubicin - adverse effects Doxorubicin - therapeutic use Humans Hyperglycemia - chemically induced Hyperglycemia - diagnosis Hyperglycemia - drug therapy Hypoglycemic Agents - therapeutic use IDDM Insulin Insulin - therapeutic use Life Sciences & Biomedicine Lymphatic leukemia L‐asparaginase Male Pediatrics Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Science & Technology Thioguanine - adverse effects Thioguanine - therapeutic use Treatment Outcome Vincristine - adverse effects Vincristine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	1328-8067 1442-200X
DOI:	10.1111/ped.14079